Compositions and methods for treating ischemia and...

Details Compositions and methods for treating ischemia and... Compositions and methods for treating ischemia and...

2011-04-19

2011-04-19

Bradley, Christina (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021910

Reexamination Certificate

active

07928067

ABSTRACT:
The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula II:and methods of using such compounds to activate cytoprotective kinases.

REFERENCES:
patent: 3875207 (1975-04-01), Iselin et al.
patent: 5288706 (1994-02-01), Yamanouchi et al.
patent: 5318987 (1994-06-01), Weithmann et al.
patent: 6127339 (2000-10-01), Hatanaka et al.
patent: 6271254 (2001-08-01), Ulrich et al.
patent: 6544718 (2003-04-01), Goto
patent: 6890896 (2005-05-01), Shashoua
patent: 7524819 (2009-04-01), Shashoua
patent: 2002/0035243 (2002-03-01), Imfeld et al.
patent: 2002/0048798 (2002-04-01), Avery et al.
patent: 2004/0204340 (2004-10-01), Hamilton et al.
patent: 2005/0153291 (2005-07-01), Hartwich et al.
patent: 2006/0019901 (2006-01-01), Shashoua
patent: 2007/0287195 (2007-12-01), Suda
patent: 2009/0082281 (2009-03-01), Shashoua
patent: 2 582 027 (2007-09-01), None
patent: 0 063 879 (1989-11-01), None
patent: 0 869 126 (2002-07-01), None
patent: 1 454 627 (2004-09-01), None
patent: 9-90542 (1997-04-01), None
patent: 11-7099 (1999-01-01), None
patent: 2003-286168 (2003-10-01), None
patent: 2004-51624 (2004-02-01), None
patent: 2006-22066 (2006-01-01), None
patent: WO 93/22320 (1993-11-01), None
patent: WO 97/18235 (1997-05-01), None
patent: WO 99/45922 (1999-09-01), None
patent: WO 01/09118 (2001-02-01), None
patent: WO 01/36454 (2001-05-01), None
patent: WO 02/096360 (2002-12-01), None
patent: WO 03/055853 (2003-07-01), None
patent: WO 03/070714 (2003-08-01), None
patent: WO 03/072052 (2003-09-01), None
patent: WO 2004/004632 (2004-01-01), None
patent: WO 2005/063732 (2005-07-01), None
patent: WO 2006/101909 (2006-09-01), None
patent: WO 2006/101910 (2006-09-01), None
patent: WO 2006/117995 (2006-11-01), None
CAPLUS Accession No. 2006:1007709, published 2006.
Hardesty et al. “Enzymatic Proteolysis of a Surface-Bound α-Helical Polypeptide” Langmuir, 2008, 24, 13944-13956.
CAPLUS Accession No. 2008:1371872, published 2008.
CAPLUS Accession No. 2006:1007709, CAS abstract for Kates, WO 2006101909, published 2006.
Bastin et al. “Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities,” Organic Process Res. & Dev, 2000, 4, 427-35.
img id="CUSTOM-CHARACTER-00001" he="3.13mm" wi="1.78mm" file="US07928067-20110419-P00001.TIF" alt="custom character" img-content="character" img-format="tif" ?ehirli et al. (“-Lipoic Acid Protects Against Renal Ischaemia-Reperfusion Injury in Rats,” Clin. Exp. Pharmacol. Phys., 2008, 35, 249-55).
Berg, Tymoczko and Stryer, Biochemistry, 5th ed., 2001 pp. 43, 467, 468.
“Nomenclature Policy: Generic Descriptors and Trivial Names for Vitamins and Related Compounds,” Am J Clin Nutr 1988 47: 581-588.
Branden & Tooze, Introduction to Protein Structure 2nd Ed., 1999, pp. 4-5.
Creighton, Proteins: Structure and Molecular Properties 2nd Ed., 1984, p. 2.
“Nomenclature Policy: Abbreviated Designations of Amino Acids,” Am J Clin Nutr, 1988, 47, 589.
Fields & Noble “Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids,” Int. J. Peptide Protein Res., 1990, 35, 161-214.
1999 NovaBiochem Catalog & Peptide Synthesis Handbook, pp. x, xi, 1, 2, 18, 19.
Bunjes et al. “Thiopeptide-Supported Lipid Layers on Solid Substrates,” Langmuir, 1997, 13, 6188-6194.
Jun. 1995 Sigma Peptides and Amino Acids Catalog, pp. 143-144.
Zimmer et al. “Enantioselective synthesis of (S)- and (R)-6-hydroxy-8-nonenecarboxylates by asymmetric catalysis: a formal synthesis of (R)-a-lipoic acid and its (S)-antipode,” Tetrahedron: Asymmetry, 2000, 11, 879-887.
Adger et al. “The Synthesis of (R)-(+)-Lipoic Acid using a Monooxygenase-Catalysed Biotransformation as the Key Step,” Bioorganic & Medicinal Chemistry, 1997, 5, 253-261.
Pick et al. “Glutathione Reductase and Lipoamide Dehydrogenase Have Opposite Stereospecificities for α-Lipoic Acid Enantiomers,” Biochem. Biophys. Res. Comm., 1995, 206, 724-730.
Biewenga, G., et al., “The Pharmacology of the Antioxidant Lipoic Acid,”Gen. Pharmac: 29(3):315-331 (1997).
Packer, L., et al., “Molecular Aspects of Lipoic Acid in the Prevention of Diabetes Complications,”Nutrition17:888-895 (2001).
Wolz, P. and Krieglstein, J., “Neuroprotective Effects of α-Lipoic Acid and Its Enantiomers Demonstrated in Rodent Models of Focal Cerebral Ischemia,”Neuropharmacology, 35(3):369-375 (1996).

Affiliated with

Also associated with

Rating

Compositions and methods for treating ischemia and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating ischemia and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating ischemia and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2629013